Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Argus Health
Merck
Chubb
Cerilliant
UBS
Cantor Fitzgerald
Fish and Richardson

Generated: May 25, 2018

DrugPatentWatch Database Preview

LOCHOLEST LIGHT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Locholest Light, and when can generic versions of Locholest Light launch?

Locholest Light is a drug marketed by Sandoz and is included in one NDA.

The generic ingredient in LOCHOLEST LIGHT is cholestyramine. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for LOCHOLEST LIGHT
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:LOCHOLEST LIGHT at DailyMed
Drug patent expirations by year for LOCHOLEST LIGHT

US Patents and Regulatory Information for LOCHOLEST LIGHT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz LOCHOLEST LIGHT cholestyramine POWDER;ORAL 074562-001 Aug 15, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz LOCHOLEST LIGHT cholestyramine POWDER;ORAL 074562-002 Aug 15, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Baxter
McKesson
Cerilliant
US Department of Justice
Express Scripts
Chinese Patent Office
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.